Global Registry
A4D-Ab
Teneliximab
A4DAB260
|
Phase-II
Target
TNFRSF5/CD40
Isotype / Subclass
G1 / None
Company
Bristol-Myers Squibb
Clinical Status
Phase-II
Format
Whole mAb
Synonyms
Chi220
pH Formulation
—
IMGT
PubChem (135274809)
PubChem (160676923)
PubChem (472399231)
PubChem (474488753)
PubChem (474489065)
PubChem (498139709)
Thera-SAbDab
YAbS
Avg A4D Score
-0.7277
Score Range
-0.73
Structures
1
Show Structure Profiles
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity
Associated Structural Profiles
Level 2
Export CSV
Column Filters
Min Seq. Identity (%)
0
Min Avg A4D Score
-5.0
Max Avg A4D Score
2.0
Min pH (min agg. prop.)
0.0
Max pH (max agg. prop.)
14.0
Reset Filters
Structure ID
Source PDB
Seq. Identity
Avg. A4D Score
pH (Min Agg.)
pH (Max Agg.)
Score CDR
Score non-CDR
A4DAB260_5dmi_H_L
5dmi
100%
-0.7277
6.5
9.0
-0.309
-0.7807